StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
ResMed
180.13
+3.16%
 

RMD

 

ResMed

$ 180.13

 
+$5.52 | +3.16%
 
 
Open
$ 176.20
 
 
MKT CAP
$ 26.50B
 
High
$ 180.19
 
 
VOL
$ 548.96K
 
Low
$ 175.21
 
 
AVG VOL
$ 0.98M
 
 
 

RMD Stock Analysis

  Login to display ResMed (RMD) recommendation from the last 90 days from financial news and social media.
 
 

RMD Total Score

 
 

Strengths

RMD Rewards

 Earnings are forecast to grow

RMD Rewards

 Analysts raised price target

 

Risk Analysis

RMD Risk Analysis

 Downgraded on weak valued

 
 

Chart

 
 

176.82

164

144.2

212.12

 
 
1month
3month
6month
1year
 

RMD Risk Level

This Indicator assigning RMD risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
RMD Risk Level
LOW
HIGH

Risk Volatility

 

RMD has Low Risk Level

Click here to check what is your level of risk

 

RMD Analysts Opinion

RMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.67
 

RMD Earnings Sentiment

 Above analyst estimates

RMD Earnings Sentiment

 Reported a strong earnings

RMD Earnings Sentiment

 Earnings decline YoY

 
 

Rating

×
 

Rating

2.00
 

RMD Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

3.67
 

RMD Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

2.50
 
 

Future

×
 

Future

3.63
 

RMD Future Sentiment

 Earnings are forecast to grow

RMD Future Sentiment

 Analysts raised price target

 
 

RMD Analysts Opinion

RMD Analysts opinion is negative but has improved from the past 3 months

 

RMD Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
54%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
67%
75%
 
On Track
On Track
On Track
 

RMD Street Opinion 

RMD Street view is bullish and have positive views on the near-term outlook

 

RMD Performance Sentiment

Sentiments overview associated with RMD events and the stock performance.
 
54%
31%
Positive
Negative
14 out of 26
events present
8 out of 26
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

RMD Earnings

The TTM reflects 12-month period, providing review of RMD financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
4,504
4,223
3,578
+12.20%
 
 
Cost of Revenue
2,022
1,867
1,554
+14.07%
 
 
Gross Profit
2,482
2,356
2,024
+10.74%
 
 
Operating Exp
1,267
1,204
1,022
+11.34%
 
 
Operating Inc
1,215
1,152
1,002
+10.12%
 
 
Net Interest Inc
-59
-47
-22
-
 
 
Interest Exp
-
-
-
-
 
 
Interest Inc
-
-
-
-
 
 
Other Income
-59
-3
-19
-
 
 
EPS
6.17
6.12
5.34
+7.49%
 
 
Next Earnings Date: Apr 25, 2024
 
 
Highlights
Last Modify
Price
% Change

 
Dividend Declares
3 Weeks Ago
190.10
-0.95%
 
Price Target Reached
2 Month Ago
190.15
+2.04%
 
Strong Earnings
2 Month Ago
186.35
+8.48%
 
Strong Earnings
2 Month Ago
171.78
-1.82%
 
Concerns
2 Month Ago
172.76
+1.20%
 
 
 
joker
 
 
 
StocksRunner

Explore our RMD Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our RMD Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

RMD Rewards

 Earnings are forecast to grow

RMD Rewards

 Analysts raised price target

 

Risk Analysis

 

RMD Risk Analysis

 Downgraded on weak valued

 
 
 

RMD Risk Level

 
 
 

The Indicator assigning RMD risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
RMD Risk Level
LOW
HIGH

Risk Volatility

 

RMD has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

RMD

 

ResMed

$ 180.13

 
+$5.52 | +3.16%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 176.20
 
 
MKT CAP
$ 26.50B
 
High
$ 180.19
 
 
VOL
$ 548.96K
 
Low
$ 175.21
 
 
AVG VOL
$ 0.98M
 
 
 

RMD Analysis

  Sign in to view ResMed (RMD) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

176.82

164

144.2

212.12

 
 
1month
3month
6month
1year
 

RMD Analysts Opinion

RMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.67
 

RMD Earnings Sentiment

 Above analyst estimates

RMD Earnings Sentiment

 Reported a strong earnings

RMD Earnings Sentiment

 Earnings decline YoY

 
 

Rating

×
 

Rating

2.00
 

RMD Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

3.67
 

RMD Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

2.50
 
 

Future

×
 

Future

3.63
 

RMD Future Sentiment

 Earnings are forecast to grow

RMD Future Sentiment

 Analysts raised price target

 
 

RMD Analysts Opinion

RMD Analysts opinion is negative but has improved from the past 3 months

 

RMD Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
54%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
67%
75%
 
On Track
On Track
On Track
 

RMD Street Opinion 

RMD Street view is bullish and have positive views on the near-term outlook

 
RMD Performance Sentiment
Sentiments overview associated with RMD events and the stock performance.
 
54%
31%
Positive
Negative
14 out of 26
events present
8 out of 26
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

RMD Earnings

The TTM data reflects the most recent 12-month period, providing overview of RMD financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
4,504
4,223
3,578
+12.20%
 
 
Cost of Revenue
2,022
1,867
1,554
+14.07%
 
 
Gross Profit
2,482
2,356
2,024
+10.74%
 
 
Operating Exp
1,267
1,204
1,022
+11.34%
 
 
Operating Inc
1,215
1,152
1,002
+10.12%
 
 
Net Interest Inc
-59
-47
-22
-
 
 
Interest Exp
-
-
-
-
 
 
Interest Inc
-
-
-
-
 
 
Other Income
-59
-3
-19
-
 
 
EPS
6.17
6.12
5.34
+7.49%
 
 
Next Earnings Date: Apr 25, 2024
 
Highlights
Last Modify
Price
% Change

 
Dividend Declares
3 Weeks Ago
190.10
-0.95%
 
Price Target Reached
2 Month Ago
190.15
+2.04%
 
Strong Earnings
2 Month Ago
186.35
+8.48%
 
Strong Earnings
2 Month Ago
171.78
-1.82%
 
Concerns
2 Month Ago
172.76
+1.20%
 
 
RMD Latest News Feed

Notable Two Hundred Day Moving Average Cross - RMD. In trading on Wednesday shares of ResMed Inc. (Symbol: RMD) crossed below their 200 day moving average of $178.90 changing hands as low as $175.44 per share. ResMed Inc. shares are currently

Wed Feb 28, 2024

Momentum

ResMed (RMD) Price Target Increased by 9.24% to 205.30. The average one-year price target for ResMed (NYSE:RMD) has been revised to 205.30 / share. This is an increase of 9.24% from the prior estimate of 187.94 dated January

Sat Feb 24, 2024

Potential

Heres Why Investors Should Retain ResMed (RMD) Stock for Now. ResMed Inc. RMD is well-poised for growth in the coming quarters backed by the global supply of its cloud-connected platforms AirSe

Tue Feb 20, 2024

Potential

vivos therapeutics highlights significant favorable market developments creating exciting new growth opportunities. littleton colo. feb. 06 2024 (globe newswire) -- vivos therapeutics inc. (the ".company". or ".vivos".) vvos a leading medical

Tue Feb 6, 2024

Momentum

ex-dividend reminder: american water works resmed and wintrust financial. looking at the universe of stocks we cover at dividend channel on 2/7/24 american water works co inc. (symbol: awk) resmed inc. (symbol: rmd) and wintrust financial co

Mon Feb 5, 2024

Activity

rmd crosses above average analyst target. in recent trading shares of resmed inc. (symbol: rmd) have crossed above the average analyst 12-month target price of $184.78 changing hands for $186.35/share. when a stock reaches the target an analyst

Fri Jan 26, 2024

Potential
Potential
Rating

resmed (rmd) q2 earnings beat estimates margins expand. resmed inc.&rsquo.s rmd adjusted earnings per share (eps) for the second quarter of fiscal 2024 were $1.88 up 13.3% year over year. the m

Thu Jan 25, 2024

Earnings

resmed flexes its operating muscle sends shares flying above their 200-day line. resmed reported a strong december-quarter beat an analyst said thursday as rmd stock surged retaking its 200-day moving average. the post resmed flexes its operating muscle s

Thu Jan 25, 2024

Earnings
Momentum

earnings call: resmed reports robust q2 growth eyes digital health expansion.

Thu Jan 25, 2024

Activity

resmed declares $0.48 dividend.

Thu Jan 25, 2024

Activity

resmed inc q2 profit decreases but beats estimates. (rttnews) - resmed inc (rmd) announced earnings for second quarter that decreased from last year but beat the street estimates.

Wed Jan 24, 2024

Earnings
Earnings

resmed non-gaap eps of $1.88 beats by $0.10 revenue of $1.2b beats by $50m.

Wed Jan 24, 2024

Earnings

resmed product recall classified as most serious by fda (update).

Thu Jan 18, 2024

Activity

resmed product recall classified as most serious by fda.

Thu Jan 18, 2024

Activity

heres why investors should retain resmed (rmd) stock for now. resmed inc. rmd is well-poised for growth in the coming quarters backed by the global supply of its cloud-connected platforms airse

Wed Jan 17, 2024

Potential

heres why resmed (rmd) is a strong growth stock. it doesnt matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all invest

Wed Jan 17, 2024

Potential

resmed says its masks to remain on market despite fda classification. resmed said its respiratory masks containing magnets will remain on the market even though the United States food and drug administration classified a recall of the product as

Tue Jan 16, 2024

Activity

fda identifies resmeds recall of certain ventilator device masks with magnets as most serious. thursday) said it issome of its continuous positive airway pressure (cpap) masks with magnets due to possible magnetic interference with certain me

Fri Jan 12, 2024

Activity

us fda identifies recall of resmeds respiratory devices as most serious. the United States food and drug administration (fda) on thursday classified the recall of certain respiratory masks made by resmed as most serious as their use could cause

Thu Jan 11, 2024

Activity

demystifying resmed: insights from 5 analyst reviews. during the last three months 5 analysts shared their evaluations of resmed (nyse:) revealing diverse outlooks from ish to bearish. in the table below you'.ll find a summary of their recent ratings

Tue Jan 9, 2024

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 26 events in the last 90 days from financial news and social media. Last updated Mar 4, 2024 15:17 Wall St. time
 
 

RMD Total Score

 
 
 
 
 
 
 
StocksRunner

Discover RMD Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of RMD. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our RMD Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

RMD Stock trends

RMD Stock performance

RMD Stock analysis

RMD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker